Louis G. Lange, Director at Audentes Therapeutics, Inc. (BOLD), sold 11,000 shares at $59.60 ($656K) on 2019-12-23, disclosed to the SEC on 2019-12-27.
Open-market sale of $656k BOLD by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.60 | 1,000 | $60K | 9.1% |
| 2 | $59.60 | 10,000 | $596K | 90.9% |
| Total | $59.60 avg | 11,000 | $656K | 100% |
| Filing → |
| NAMS | BUY | 2024-02-21 | $95K | — | Filing → |
| BOLD | SELL | 2019-09-25 | $667K | — | Filing → |
| BOLD | SELL | 2019-06-26 | $1.5M | — | Filing → |